ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,166,076 | +10.8% | 170,230 | +67.7% | 0.01% | +16.7% |
| Q2 2023 | $1,052,545 | -42.5% | 101,499 | -55.1% | 0.01% | -52.0% |
| Q1 2023 | $1,829,974 | -80.7% | 226,202 | -62.5% | 0.02% | -80.3% |
| Q4 2022 | $9,489,674 | -13.5% | 602,519 | -13.6% | 0.13% | -17.0% |
| Q3 2022 | $10,971,000 | +26.4% | 697,007 | +12.1% | 0.15% | +14.2% |
| Q2 2022 | $8,677,000 | -19.0% | 621,557 | +4.5% | 0.13% | -23.4% |
| Q3 2021 | $10,706,000 | – | 594,768 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |